| Dr Elizabeth A O'connor, MD | |
|
2605 Development Dr, Green Bay, WI 54311-4240 | |
| (920) 288-8240 | |
| (920) 288-8255 |
| Full Name | Dr Elizabeth A O'connor |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 17 Years |
| Location | 2605 Development Dr, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851411854 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 52442 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Baycare Medical Ctr | Green bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baycare Clinic Llp | 4385554328 | 185 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
The Pharmaceutical Care Management Association (PCMA) has launched a new ad campaign in Maryland that highlights the core value proposition of pharmacy benefit managers.
Mount Sinai researchers have designed an artificial intelligence model that can determine whether lower back pain is acute or chronic by scouring doctors' notes within electronic medical records, an approach that can help to treat patients more accurately, according to a study published in the Journal of Medical Internet Research in February.
New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.
If someone joins a church, mosque or synagogue, they may be seeking better emotional or spiritual health. But according to research out of West Virginia University, faith communities have the potential to promote physical wellbeing, as well.
› Verified 5 days ago
| Entity Name | Baycare Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588609648 PECOS PAC ID: 4385554328 Enrollment ID: O20031105000087 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
The Pharmaceutical Care Management Association (PCMA) has launched a new ad campaign in Maryland that highlights the core value proposition of pharmacy benefit managers.
Mount Sinai researchers have designed an artificial intelligence model that can determine whether lower back pain is acute or chronic by scouring doctors' notes within electronic medical records, an approach that can help to treat patients more accurately, according to a study published in the Journal of Medical Internet Research in February.
New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.
If someone joins a church, mosque or synagogue, they may be seeking better emotional or spiritual health. But according to research out of West Virginia University, faith communities have the potential to promote physical wellbeing, as well.
› Verified 5 days ago
| Entity Name | Baycare Aurora Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255387726 PECOS PAC ID: 0244130557 Enrollment ID: O20051012000579 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
The Pharmaceutical Care Management Association (PCMA) has launched a new ad campaign in Maryland that highlights the core value proposition of pharmacy benefit managers.
Mount Sinai researchers have designed an artificial intelligence model that can determine whether lower back pain is acute or chronic by scouring doctors' notes within electronic medical records, an approach that can help to treat patients more accurately, according to a study published in the Journal of Medical Internet Research in February.
New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.
If someone joins a church, mosque or synagogue, they may be seeking better emotional or spiritual health. But according to research out of West Virginia University, faith communities have the potential to promote physical wellbeing, as well.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth A O'connor, MD 1035 Kepler Dr, Green Bay, WI 54311-8320 Ph: (920) 490-9046 | Dr Elizabeth A O'connor, MD 2605 Development Dr, Green Bay, WI 54311-4240 Ph: (920) 288-8240 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.
The Pharmaceutical Care Management Association (PCMA) has launched a new ad campaign in Maryland that highlights the core value proposition of pharmacy benefit managers.
Mount Sinai researchers have designed an artificial intelligence model that can determine whether lower back pain is acute or chronic by scouring doctors' notes within electronic medical records, an approach that can help to treat patients more accurately, according to a study published in the Journal of Medical Internet Research in February.
New technology developed by a team of McGill University scientists shows potential to streamline the analysis of proteins, offering a quick, high volume and cost-effective tool to hospitals and research labs alike.
If someone joins a church, mosque or synagogue, they may be seeking better emotional or spiritual health. But according to research out of West Virginia University, faith communities have the potential to promote physical wellbeing, as well.
› Verified 5 days ago
Dr. William J Dierberg, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 | |
Dr. James Lee, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 S Webster Ave, Ste 401, Green Bay, WI 54301 Phone: 920-436-8284 | |
Steven C Schmidt, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-288-8255 | |
Dr. Eugene H Schmitt Iii, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 S Webster Ave, Ste 401, Green Bay, WI 54301 Phone: 920-432-7000 Fax: 920-432-7451 | |
James M Zasuly, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-857-1488 |